Chronic lymphocytic leukemia clinical staging: Difference between revisions
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Splenomegaly}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Splenomegaly}} | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Lymphadenopathy}} | ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Lymphadenopathy}} | ||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Median Survival}} | |||
|- | |- | ||
| Line 32: | Line 33: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Absent | Absent | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | |||
>150 months | |||
|- | |- | ||
| Line 47: | Line 50: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Present | Present | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | |||
101 months | |||
|- | |- | ||
| Line 62: | Line 67: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Present or absent | Present or absent | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | |||
71 months | |||
|- | |- | ||
| Line 77: | Line 84: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Present or absent | Present or absent | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | |||
19 months | |||
|- | |- | ||
| Line 92: | Line 101: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Present or absent | Present or absent | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | |||
19 months | |||
|} | |} | ||
== References == | == References == | ||
Revision as of 18:42, 14 October 2015
|
Chronic lymphocytic leukemia Microchapters |
|
Differentiating Chronic lymphocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chronic lymphocytic leukemia clinical staging On the Web |
|
American Roentgen Ray Society Images of Chronic lymphocytic leukemia clinical staging |
|
Directions to Hospitals Treating Chronic lymphocytic leukemia |
|
Risk calculators and risk factors for Chronic lymphocytic leukemia clinical staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Staging System
Rai Staging System
According to the Rai Staging System, there are five stages of chronic lymphocytic leukemia based on the degree of lymphocytosis, hemoglobin level, platelets level, the presence of splenomegaly, and the presence of lymphadenopathy.[1]
| Stage | Hemoglobin Level | Platelets Level | Lymphocytosis | Splenomegaly | Lymphadenopathy | Median Survival |
|---|---|---|---|---|---|---|
|
Stage 0 |
>11 g/dL |
>100,000/L |
Present |
Absent |
Absent |
>150 months |
|
Stage 1 |
>11 g/dL |
>100,000/L |
Present |
Absent |
Present |
101 months |
|
Stage 2 |
>11 g/dL |
>100,000/L |
Present |
Present |
Present or absent |
71 months |
|
Stage 3 |
<11 g/dL |
>100,000/L |
Present |
Present or absent |
Present or absent |
19 months |
|
Stage 4 |
<11 g/dL or >11g/dL |
<100,000/L |
Present |
Present or absent |
Present or absent |
19 months |
References
- ↑ Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975). "Clinical staging of chronic lymphocytic leukemia". Blood. 46 (2): 219–34. PMID 1139039.